✦ LIBER ✦
Cilostazol, a potent phosphodiesterase type III inhibitor, selectively increases antiatherogenic high-density lipoprotein subclass LpA-I and improves postprandial lipemia in patients with type 2 diabetes mellitus
✍ Scribed by Katsunori Ikewaki; Keiko Mochizuki; Masafumi Iwasaki; Ryoichi Nishide; Seibu Mochizuki; Norio Tada
- Book ID
- 117828699
- Publisher
- Elsevier Science
- Year
- 2002
- Tongue
- English
- Weight
- 106 KB
- Volume
- 51
- Category
- Article
- ISSN
- 1532-8600
No coin nor oath required. For personal study only.